All In MedTech

Device Trial Radar · NCT06930677

Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

A Prospective, Single-arm, Multinational, Multi-center, Clinical Study to Evaluate the Performance and Safety of Musculoskeletal Embolization Using NBGM200 in Patients With Knee Degenerative Osteoarthritis

Last checked: Nov 20, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

72

Planned (sponsor's estimate)

Start

Apr 17, 2025

Primary completion

Feb 2027

Study completion Feb 2027

Sponsor

Lead sponsor
Next Biomedical Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Apr 16, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study in patients with knee osteoarthritis treated by embolization using NBGM200

Conditions

  • Knee Osteoarthritis (Knee OA)

Interventions

  • embolization therapyDevice

    MSK embolization

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Knee Injury and Osteoarthritis Outcome score (KOOS-12)Time frame: 6 months post treatment

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • University Hospital Ghent

    Ghent, Belgium · Recruiting

  • Uz Leuven

    Leuven, Belgium · Recruiting

  • Elisabeth-Tweesteden Hospital

    Tilburg, Netherlands · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.